Targeted therapies in pediatric oncology: A start

Area of Science:

• Pediatric Oncology
• Cancer Therapeutics
• Drug Development

Background:

• Conventional chemotherapy revolutionized childhood cancer treatment in the 20th century.
• While effective, conventional chemotherapy has reached its therapeutic limits.
• Targeted therapies represent the next frontier in improving outcomes for pediatric malignancies.

Purpose of the Study:

• To provide an overview of current targeted therapies for childhood cancers.
• To categorize these therapies into immunotherapies and molecular targeted therapies.
• To discuss challenges and future directions in pediatric cancer treatment.

Main Methods:

• Review of approved targeted therapy drugs.
• Analysis of drugs in early-phase clinical trials (past and present).
• Categorization based on therapeutic class (immunotherapy, molecularly targeted).

Main Results:

• Overview of the spectrum of available targeted therapies.
• Identification of approved agents and those in clinical development.
• Discussion of advancements beyond conventional chemotherapy.

Conclusions:

• Targeted therapies are significantly improving pediatric oncology outcomes.
• Further research is needed to overcome challenges and advance new treatments.
• Innovations aim for greater efficacy with reduced toxicity in childhood cancers.